Primary |
Hypertension |
51.1% |
Atrial Fibrillation |
5.7% |
Diabetes Mellitus |
5.0% |
Essential Hypertension |
4.7% |
Depression |
4.6% |
Dyslipidaemia |
2.9% |
Blood Pressure Abnormal |
2.5% |
Angina Pectoris |
2.4% |
Arrhythmia |
2.4% |
Type 2 Diabetes Mellitus |
2.4% |
Acute Coronary Syndrome |
2.2% |
Myocardial Ischaemia |
1.9% |
Blood Pressure |
1.7% |
Cardiac Disorder |
1.6% |
Constipation |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Myocardial Infarction |
1.5% |
Renal Failure Chronic |
1.5% |
Tachycardia |
1.5% |
Cardiac Failure |
1.4% |
|
Hypertension |
14.2% |
Suicide Attempt |
10.3% |
Shock |
5.6% |
Malaise |
5.2% |
Myocardial Infarction |
5.2% |
Syncope |
5.2% |
Hypotension |
4.7% |
Somnolence |
4.7% |
Dizziness |
4.3% |
Drug Interaction |
4.3% |
Renal Failure |
4.3% |
Sinus Bradycardia |
4.3% |
Hepatic Function Abnormal |
3.9% |
Vomiting |
3.9% |
Bradycardia |
3.4% |
Cytolytic Hepatitis |
3.4% |
Loss Of Consciousness |
3.4% |
Paraesthesia |
3.4% |
Tachycardia |
3.4% |
Hepatitis |
3.0% |
|
Secondary |
Hypertension |
29.4% |
Drug Use For Unknown Indication |
16.2% |
Product Used For Unknown Indication |
10.4% |
Depression |
9.1% |
Diabetes Mellitus |
5.8% |
Atrial Fibrillation |
3.3% |
Myocardial Ischaemia |
2.7% |
Essential Hypertension |
2.6% |
Dyslipidaemia |
2.4% |
Tachyarrhythmia |
2.4% |
Blood Pressure Abnormal |
2.3% |
Hypercholesterolaemia |
2.0% |
Type 2 Diabetes Mellitus |
2.0% |
Ventricular Extrasystoles |
1.9% |
Intentional Overdose |
1.6% |
Anxiety |
1.3% |
Ill-defined Disorder |
1.3% |
Colorectal Cancer Metastatic |
1.2% |
Heart Rate Increased |
1.2% |
Acute Coronary Syndrome |
1.1% |
|
Myocardial Infarction |
11.3% |
Shock |
8.7% |
Suicide Attempt |
8.7% |
Hypotension |
7.7% |
Hypoglycaemia |
5.1% |
Malaise |
5.1% |
Tachycardia |
5.1% |
Renal Failure |
4.6% |
Weight Decreased |
4.6% |
Loss Of Consciousness |
4.1% |
Renal Failure Acute |
4.1% |
Syncope |
4.1% |
Fall |
3.6% |
Fatigue |
3.6% |
Feeling Abnormal |
3.6% |
Medication Error |
3.6% |
Cough |
3.1% |
Drug Ineffective |
3.1% |
Pneumonia |
3.1% |
Rhabdomyolysis |
3.1% |
|
Concomitant |
Hypertension |
26.2% |
Product Used For Unknown Indication |
17.5% |
Drug Use For Unknown Indication |
15.0% |
Prophylaxis |
4.3% |
Diabetes Mellitus |
4.0% |
Depression |
3.7% |
Rheumatoid Arthritis |
3.5% |
Atrial Fibrillation |
3.0% |
Pain |
3.0% |
Osteoporosis |
2.9% |
Blood Cholesterol Increased |
2.3% |
Multiple Myeloma |
2.0% |
Anxiety |
1.9% |
Insomnia |
1.8% |
Type 2 Diabetes Mellitus |
1.6% |
Gastrooesophageal Reflux Disease |
1.6% |
Hyperlipidaemia |
1.5% |
Arthritis |
1.4% |
Angina Pectoris |
1.4% |
Cardiac Disorder |
1.3% |
|
Vomiting |
11.7% |
Weight Decreased |
9.3% |
Weight Increased |
7.4% |
Myocardial Infarction |
6.0% |
Renal Failure Acute |
5.5% |
Nausea |
5.4% |
Thrombocytopenia |
5.1% |
Urinary Tract Infection |
5.0% |
Pneumonia |
4.5% |
Rash |
4.3% |
Type 2 Diabetes Mellitus |
4.3% |
Death |
4.2% |
White Blood Cell Count Decreased |
4.1% |
Hypertension |
3.7% |
Tremor |
3.5% |
Vision Blurred |
3.5% |
Renal Failure |
3.3% |
Oedema Peripheral |
3.2% |
Drug Ineffective |
3.1% |
Pyrexia |
3.1% |
|
Interacting |
Acute Coronary Syndrome |
19.7% |
Diabetes Mellitus |
11.7% |
Depression |
11.3% |
Hypertension |
8.9% |
Tachyarrhythmia |
5.6% |
Agitation |
4.7% |
Angina Pectoris |
4.7% |
Prophylaxis Against Gastrointestinal Ulcer |
4.2% |
Atrial Fibrillation |
3.8% |
Drug Use For Unknown Indication |
3.8% |
Dyslipidaemia |
3.3% |
High Density Lipoprotein Decreased |
2.3% |
Schizophrenia, Paranoid Type |
2.3% |
Smoking Cessation Therapy |
2.3% |
Blood Cholesterol Increased |
1.9% |
Dementia |
1.9% |
Hypercholesterolaemia |
1.9% |
Hypothyroidism |
1.9% |
Phaeochromocytoma |
1.9% |
Polyneuropathy |
1.9% |
|
Drug Interaction |
17.6% |
Hepatitis Cholestatic |
13.7% |
Myocardial Infarction |
11.8% |
Syncope |
7.8% |
Hypotension |
5.9% |
Psoriasis |
5.9% |
Sinus Arrest |
5.9% |
Hypertensive Crisis |
3.9% |
Shock |
3.9% |
Sinus Bradycardia |
3.9% |
Angina Pectoris |
2.0% |
Electrolyte Imbalance |
2.0% |
Hepatitis Toxic |
2.0% |
Hypoglycaemia |
2.0% |
International Normalised Ratio Increased |
2.0% |
Oral Intake Reduced |
2.0% |
Prostate Cancer |
2.0% |
Sinus Disorder |
2.0% |
Stress |
2.0% |
Tobacco User |
2.0% |
|